# Hikma Pharmaceuticals upgraded to ‘BBB’ by Fitch with stable outlook

- Link: https://www.directorstalkinterviews.com/hikma-pharmaceuticals-upgraded-to-bbb-by-fitch-with-stable-outlook/4121199062
- Published: 2025-05-29T07:34:43+01:00
- Author: Amilia Stone

**[Hikma Pharmaceuticals PLC](https://www.directorstalkinterviews.com/ftse-company/hikma-pharmaceuticals/hik.l)**(
LON:HIK) has announced that Fitch has upgraded its long-term issuer default rating
and the senior unsecured rating on Hikma Finance USA LLC’s $500 million notes to‘
BBB’ from ‘BBB-‘ with a stable outlook. 

> **Khalid Nabilsi, CFO of Hikma Pharmaceuticals said**: “I am pleased that now 
> both Fitch and S&P have upgraded Hikma to BBB, reinforcing our investment grade
> rating. These upgrades are a strong endorsement of our strategic direction, financial
> discipline, and operational resilience. They underscore Hikma’s solid market position
> across key geographies and reflect confidence in our ability to consistently deliver
> strong financial results, supported by our diversified business model, robust 
> balance sheet, and prudent capital allocation.”

Share on: